https://www.selleckchem.com/pr....oducts/pirtobrutinib
Most used sheaths were 8F (46%) and 9F (37%), mostly for 20mm (50%) and 23mm (38%) balloons. There were neither major procedural complications (neither balloon entrapment nor compartmental syndrome) nor minor complications (any accesssite bleeding). RAO was observed in 2 patients (8%), both asymptomatic. TRBAV was safe, feasible, and efficacious with a small rate of conversion and RAO, suggesting reproducibility of this novel technique. TRBAV may represent an alternative to femoral access in selected patients although lar
Like
Comment
Share
